JHS Svendgaard Laboratories (NSE:JHS) Other Current Payables: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JHS JHS Svendgaard Laboratories Ltd NSE:JHS
50 GF Score
Price ₹7.39
GF Value ₹22.86
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is JHS Svendgaard Laboratories Other Current Payables?

JHS Svendgaard Laboratories NSE:JHS -0.14% 50 Other Current Payables is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:JHS with a GF Score™ of 50/100 and a GF Value™ of ₹22.86 (Possible Value Trap). The stock has 3 warning signs investors should review.

JHS Svendgaard Laboratories's Other Current Payables for the quarter that ended in Mar. 2026 was ₹0 Mil.

JHS Svendgaard Laboratories's annual Other Current Payables increased from Mar. 2024 (₹49 Mil) to Mar. 2025 (₹51 Mil) but then declined from Mar. 2025 (₹51 Mil) to Mar. 2026 (₹0 Mil).

JHS Svendgaard Laboratories Other Current Payables Related Terms

JHS Svendgaard Laboratories Other Current Payables Historical Data

* Premium members only.

The historical data trend for JHS Svendgaard Laboratories's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JHS Svendgaard Laboratories Other Current Payables Chart

JHS Svendgaard Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.76 49.60 48.52 50.86 0.00

JHS Svendgaard Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.86 0.00 0.00 0.00 0.00
NSE:JHS
50GF Score
JHS Svendgaard Laboratories Ltd NSE:JHS
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JHS Svendgaard Laboratories Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0 Mil mean?
JHS Svendgaard Laboratories (NSE:JHS) has a Other Current Payables of ₹0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on JHS Svendgaard Laboratories and its competitors.
Is JHS Svendgaard Laboratories' Other Current Payables too high?
JHS Svendgaard Laboratories' current Other Current Payables is ₹0 Mil. Overall, JHS Svendgaard Laboratories has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JHS Svendgaard Laboratories' Other Current Payables compare to PG and CL?
JHS Svendgaard Laboratories' Other Current Payables of ₹0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Consumer Packaged Goods company?
A good Other Current Payables depends on the Consumer Packaged Goods industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on JHS Svendgaard Laboratories and its competitors. JHS Svendgaard Laboratories's current Other Current Payables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JHS Svendgaard Laboratories stock overvalued right now?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories (NSE:JHS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹22.86, compared to a current price of ₹7.39 — trading 67.7% below its estimated fair value. The current Other Current Payables is ₹0 Mil. JHS Svendgaard Laboratories' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For JHS Svendgaard Laboratories (NSE:JHS), the current Other Current Payables is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JHS Svendgaard Laboratories (NSE:JHS) Overvalued in 2026?

Based on GuruFocus' analysis, JHS Svendgaard Laboratories stock appears to be undervalued. The current stock price of ₹7.39 is trading 67.7% below its estimated GF Value™ of ₹22.86. GuruFocus considers JHS Svendgaard Laboratories to be Possible Value Trap.

Key valuation signals for NSE:JHS:

  • Other Current Payables: ₹0 Mil
  • GF Value™: ₹22.86 vs. price of ₹7.39 (67.7% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the NSE:JHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JHS Svendgaard Laboratories Business Description

Other Exchanges 532771:India
Address Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044
JHS Svendgaard Laboratories Ltd is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portfolio of the Group is to carry out manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanizers, and job work of detergent powder. The Company is into manufacturing toothpaste, toothbrushes, Talcum, and Others. The toothbrushes segment generates the key revenue.
50GF Score

Get the complete analysis for NSE:JHS

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.39
Price
₹22.86
GF Value